Skip to main content
Premium Trial:

Request an Annual Quote

ASHG Awards $10,000 to Children s Hospital Geneticist for Muscular Dystrophy Research

NEW YORK, Oct. 26 (GenomeWeb News) - The American Society of Human Genetics has awarded Louis Kunkel, director of the genomics program at Children's Hospital Boston, with its annual Allan Award for his work on the genetics of muscular dystrophy, the Children's Hospital said on Monday.

 

Kunkel will receive $10,000 in recognition of his research, according to a Children's Hospital spokesperson. In 1986, Kunkel discovered the gene that causes Duchenne muscular dystrophy, and subsequently defined the genetic characteristics of the critical muscle protein dystrophin, as well as several dystrophin-associated proteins.

 

Kunkel's lab is currently using microarray technology to examine the activity of multiple genes involved in the disease, the Children's Hospital said.

 

ASHG's Allan Award recognizes "substantial and far-reaching contributions to human genetics carried out over a sustained period of scientific inquiry and productivity," according to an official statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.